PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31025080-1	2019	Sunitinib (SNT) is a multi-targeted receptor tyrosine kinase inhibitor that has been approved by the FDA for cancer therapy.	Sunitinib	0-9	ret proto-oncogene	Homo sapiens	36-60	
31025080-1	2019	Sunitinib (SNT) is a multi-targeted receptor tyrosine kinase inhibitor that has been approved by the FDA for cancer therapy.	Sunitinib	11-14	ret proto-oncogene	Homo sapiens	36-60